These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Life events, daily stresses and coping in patients with Graves' disease. Kung AW Clin Endocrinol (Oxf); 1995 Mar; 42(3):303-8. PubMed ID: 7758236 [TBL] [Abstract][Full Text] [Related]
8. Stressful life events and smoking were associated with Graves' disease in women, but not in men. Yoshiuchi K; Kumano H; Nomura S; Yoshimura H; Ito K; Kanaji Y; Ohashi Y; Kuboki T; Suematsu H Psychosom Med; 1998; 60(2):182-5. PubMed ID: 9560867 [TBL] [Abstract][Full Text] [Related]
9. Stressful life events, depression and demoralization as risk factors for acute coronary heart disease. Rafanelli C; Roncuzzi R; Milaneschi Y; Tomba E; Colistro MC; Pancaldi LG; Di Pasquale G Psychother Psychosom; 2005; 74(3):179-84. PubMed ID: 15832069 [TBL] [Abstract][Full Text] [Related]
10. [Stressful life events and depressive disorders as risk factors for acute coronary heart disease]. Rafanelli C; Pancaldi LG; Ferranti G; Roncuzzi R; Tomba E; Milaneschi Y; Marcolin F; Colistro MC; Di Pasquale G Ital Heart J Suppl; 2005 Feb; 6(2):105-10. PubMed ID: 15822734 [TBL] [Abstract][Full Text] [Related]
11. Course of depression in Cushing's syndrome: response to treatment and comparison with Graves' disease. Sonino N; Fava GA; Belluardo P; Girelli ME; Boscaro M Horm Res; 1993; 39(5-6):202-6. PubMed ID: 8314204 [TBL] [Abstract][Full Text] [Related]
12. Effect of stressful life events on the initiation of graves' disease. Topcu CB; Celik O; Tasan E Int J Psychiatry Clin Pract; 2012 Oct; 16(4):307-11. PubMed ID: 22136213 [TBL] [Abstract][Full Text] [Related]
13. Relationship between the number and impact of stressful life events and the onset of Graves' disease and toxic nodular goitre. Matos-Santos A; Nobre EL; Costa JG; Nogueira PJ; Macedo A; Galvão-Teles A; de Castro JJ Clin Endocrinol (Oxf); 2001 Jul; 55(1):15-9. PubMed ID: 11453947 [TBL] [Abstract][Full Text] [Related]
15. Chronic recurrent stress due to panic disorder does not precipitate Graves' disease. Chiovato L; Marinò M; Perugi G; Fiore E; Montanelli L; Lapi P; Cavaliere R; Ciampi M; Patronelli A; Placidi G; Placidi GF; Cassano GB; Pinchera A J Endocrinol Invest; 1998 Dec; 21(11):758-64. PubMed ID: 9972676 [TBL] [Abstract][Full Text] [Related]
16. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology. Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology, management and outcomes of Graves' disease-real life data. Hussain YS; Hookham JC; Allahabadia A; Balasubramanian SP Endocrine; 2017 Jun; 56(3):568-578. PubMed ID: 28478488 [TBL] [Abstract][Full Text] [Related]
18. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment. Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255 [TBL] [Abstract][Full Text] [Related]
19. Studies on the occurrence of ophthalmopathy in Graves' disease. Marcocci C; Bartalena L; Bogazzi F; Panicucci M; Pinchera A Acta Endocrinol (Copenh); 1989 Apr; 120(4):473-8. PubMed ID: 2718699 [TBL] [Abstract][Full Text] [Related]